Truscreen Annual Meeting

1



TRUSCREEN LIMITED

NOTICE OF ANNUAL MEETING OF SHAREHOLDERS

Notice is given that the Meeting will be held at:
TIME: 12:00pm
DATE: Thursday 10 September 2020
PLACE: Online at www.virtualmeeting.co.nz/tru20




The business of the Meeting affects your shareholding and your vote is important.
This Notice of Meeting should be read in its entirety. If Shareholders are in doubt as to how they
should vote, they should seek advice from their professional advisers prior to voting.
Persons eligible to vote at the Meeting are those who are registered Shareholders at 5:00pm on
Tuesday 8 September 2020.

2

Notice is hereby given that the Annual Meeting of Shareholders of Truscreen Limited (the
"Company”) will be held online at www.virtual meeting.co.nz/tru20 on Thursday 10 September 2020
at 12.00pm.
BUSINESS OF THE MEETING
AGENDA
FINANCIAL STATEMENTS AND REPORTS
To receive and consider the Annual Report of the Company for the financial year ended 31
March 2020. A presentation will be made by Ms Victoria Potarina, Chief Executive Office
of Truscreen Limited.
To consider and, if thought fit, pass the following ordinary resolutions:
1. APPOINTMENT OF AUDITORS – ORDINARY RESOLUTION
That the Shareholders ratify the appointment of RSM Hayes Audit Auckland on 17 February
2020.
2. REMUNERATION OF AUDITORS – ORDINARY RESOLUTION
That the Board be authorised to fix the remuneration of RSM Hayes Audit Auckland the
Company’s auditors.
3. ELECTION OF JULIET HULL AS A DIRECTOR – LISTING RULE 2.3.1 - ORDINARY
RESOLUTION
That Ms Juliet Hull, who was nominated as a non-executive director of the Company, and
having consented to act, be elected as a Director of the Company.
A summary of Ms Hull qualifications and experience is included in the Explanatory Notes.
4. RE-ELECTION OF ANTHONY HO AS A DIRECTOR – LISTING RULE 2.2.1(b) -
ORDINARY RESOLUTION
That Mr Anthony Ho, who retires in accordance with the provisions of the Constitution of
the Company, and being eligible, offers himself for re-election, be re-elected as a Director
of the Company.
5. RATIFICATION OF PRIOR ISSUE OF 34,860,021 SHARES – LISTING RULE 4.5.1(c) -
ORDINARY RESOLUTION
That shareholders ratify the previous issue by the Company on 21 May 2020 of 34,860,021
ordinary fully paid shares at an issue price of 5 cents per share.
6. RATIFICATION OF PRIOR ISSUE OF 10,000,000 SHARES – LISTING RULE 4.5.1(c) -
ORDINARY RESOLUTION
That shareholders ratify the previous issue by the Company on 29 May 2020 of 10,000,000
ordinary fully paid shares at an issue price of 5 cents per share.

3

7. RATIFICATION OF PRIOR ISSUE OF 20,000,000 SHARES – LISTING RULE 4.5.1(c) -
ORDINARY RESOLUTION
That shareholders ratify the previous issue by the Company on 5 June 2020 of 20,000,000
ordinary fully paid shares at an issue price of 5 cents per share.


By Order of the Board of Directors

Anthony Ho
Chairman


VOTING BY PROXY
All shareholders of the Company entitled to attend and vote at the meeting, may attend the meeting, or are
entitled to appoint a proxy to attend and vote on their behalf.
A proxy appointment and vote can be completed online at the Link Market Services Investor Centre at
https://investorcentre.linkmarketservices.co.nz/voting/TRU. You will require your CSN/Holder Number and
Authorisation Code (FIN).
Alternatively, please complete and sign the enclosed Proxy Form and return to the Company’s Share Registrar,
Link Market Services in accordance with the instructions set out on the Proxy Form accompanying this Notice
by 12.00 noon on Tuesday 8 September 2020.
Shareholders are advised that:
• each Shareholder has a right to appoint a proxy;
• Shareholders may appoint the Chair as their proxy; and
• the proxy need not be a Shareholder.

Shareholders and their proxies should be aware that
• if proxy holders vote, they must cast all directed proxies as directed; and
• any directed proxies which are not voted will automatically default to the Chair, who must vote the proxies
as directed.
Directed proxies means the proxy holder will vote on each resolution as directed by the Shareholder. In the
event the Shareholder does not indicate how the proxy holder should vote on each resolution, and the
Shareholder appoints the Chair as their proxy, the Chair will vote all resolutions in favour of all of the resolutions,
except those in which the Chair has an interest.

4

VOTING RESTRICTIONS
Those persons who are prohibited from voting on a resolution may not act as a discretionary proxy in respect of
a resolution, but may vote in accordance with express instructions.

The Chairperson shall vote any undirected proxies in favour of all of the resolutions.

The persons identified in Column 2 of the table below are unable to Vote in favour of the resolutions listed in
Column 1.

Column 1
Resolution
Column 2
Disqualified Person
Resolutions 5, 6 and 7 Any person who has been issued, or has acquired, the Equity Securities which
are subject to ratification by that resolution, and any Associated Person of that
person.

5

Explanatory Notes
NZX Listing Rules (“Listing Rules”) and Companies Act (“Act”)

The Company is listed on the NZX Main Board and must comply with the Listing Rules and the Act.
In addition, various provisions of the Listing Rules are included in the Constitution. The Act, the
Constitution and the Listing Rules contain specific requirements which are relevant to the resolutions
comprised in this Notice.

The implications of the Listing Rules, the Act and the Constitution, insofar as they relate to each
resolution, are addressed in the Explanatory Notes to each resolution.

Nature of Resolutions
The resolutions which are to be considered at the Meeting are all ordinary resolutions. An ordinary
resolution is a resolution passed by a simple majority of votes of shareholders of the Company,
entitled to vote and voting.

These Explanatory Notes have been prepared to provide information which the Directors believe to
be material to Shareholders in deciding whether or not to pass the Resolutions.
AGENDA ITEM 1 - FINANCIAL STATEMENTS AND REPORTS
Whilst the consideration of the Annual Report by shareholders is not strictly required under the Act,
the Board considers it good policy to table the Annual Report at the Meeting for consideration by
shareholders, and for discussion where appropriate.
The Company will not provide a hard copy of the Company’s annual financial report to Shareholders
unless specifically requested to do so. The Company’s annual financial report is available on its
website at www.truscreen.com.
1. RESOLUTION 1 - APPOINTMENT OF AUDITORS – ORDINARY RESOLUTION

BDO resigned as the auditor and RSM Hayes Audit Auckland was appointed auditor of the Company
under section 207R of the Companies Act 1993, on 17 February 2020. This resolution seeks
ratification of this casual appointment by the shareholders.

2. RESOLUTION 2 - REMUNERATION OF AUDITORS – ORDINARY RESOLUTION

This resolution authorises the Board to fix the fees and expenses of the auditor.

3. RESOLUTION 3 - ELECTION OF MS JULIET HULL AS A DIRECTOR – ORDINARY
RESOLUTION
3.1 Because of his growing business commitments, Mr. Kelly (Con) Hickey advised the board in early
2020 of his intention not to seek re-election at the 2020 annual general meeting of shareholders.

A nomination was received prior to closing date, for the nomination of Juliet Hull as a Director of the
Company per Listing Rule 2.3.2(e). No other nominations were received.

The board has received a nomination from a shareholder to appoint Ms Juliet Hull as a Director of
the Company at the annual general meeting, to fill the planned vacancy from the retirement of Mr.
Hickey. The board recommends shareholders to vote in favour of this resolution.

3.2 The qualifications and material directorships of Ms Juliet Hull are outlined below:
Ms Hull has an MBA from the Macquarie Graduate School of Management, Sydney Australia, and a
Batchelor of Nursing from the Auckland Technical Institute.

6

Ms Hull is the NZ General Manager/Country Director for Johnson & Johnson Medical in New Zealand
and has held various roles in Johnson & Johnson in Australia and New Zealand since 2012.
Ms Hull has more than twenty years’ experience working in Asia and Pacific markets in Healthcare,
in sales, Marketing and leadership.
3.3 The Board is of the view that Mrs Juliet Hull qualifies as an “independent director” of the Company
(as that term is defined in the Listing Rules).
3.4 Ms Juliet Hull is a resident of Auckland, New Zealand
4. RESOLUTION 4 - RE-ELECTION OF ANTHONY HO AS A DIRECTOR – ORDINARY
RESOLUTION
4.1 In terms of the constitution of the Company and the Listing Rules, Mr Anthony Ho is required to
retire from his role as a director of the Company at the Annual General Meeting. Mr Anthony Ho is
eligible to be re-elected as a director at the Annual General Meeting.

4.2 The qualification and material directorships of Mr Anthony Ho is as outlined below:
Independent Non-Executive Chairman BCom UNSW, CA, FCIS, FAICD, FGIA
Tony has a Bachelor of Commerce degree from The University of New South Wales, Sydney, and is
a Member of The Institute of Chartered Accountants in Australia and New Zealand, a Fellow of the
Australian Institute of Company Directors, a Fellow of the Institute of Chartered Secretaries and
Administrators, and the Governance Institute of Australia. He has also completed post graduate
studies in Marketing at the University of Technology, Sydney, and a past Fellow of the Australian
Marketing Institute
Tony holds numerous non-executive directorships with a number of ASX and NZX listed companies.
He is currently the non-executive chairman of Bioxyne Limited (ASX:BXN), Greenland Minerals
Limited (ASX:GGG), and Cannasouth Limited (NZX:CBD).
Tony was executive director of Arthur Yates & Co Limited, retiring from that position in April 2002.
He was previously a director of Yates New Zealand Limited. Prior to joining commerce, Tony was
a partner of Cox Johnston & Co, Chartered Accountants, which has since merged with Ernst & Young.

4.3 The Board is of the view that Mr Anthony Ho qualifies as an “independent director” of the
Company (as that term is defined in the Listing Rules).
4.4 The Board (with Mr Ho abstaining) recommends that shareholders vote in favour of this
resolution.

7

RESOLUTIONS 5, 6 AND 7.
In April/May 2020 the Company undertook a Share Purchase Plan (SPP). The SPP was substantially
oversubscribed and as a consequence the company issued the following shares in June and July.
Shares Issued % of issued capital
before issue of
shares other than
SPP shares
% of issued capital
after all issues
Opening shares on
issue
227,534,804
Share Purchase Plan 40,000,000
SPP Oversubscriptions
and Wholesale
Placement


34,860,021


13.03%


10.48%
Public Pool Offer 10,000,000 3.74% 3.00%
Priority Offer 20,000,000 7.48% 6.00%
332,394,825 24.25% 19.48%

Listing Rule 4.5.1 permits an issue of shares up to 15% in any 12 month period without prior
shareholder approval.
On 19 March 2020 the NZX under a class waiver from Section 4 of the NZX Listing Rules increased
the placement cap under Listing Rule 4.5.1 from 15% to 25% until 31 October 2020. The Company
has availed itself of the additional capacity for the Public Pool and Priority Offers in resolutions 6 and
7.

The Company relied on this class waiver to raise additional capital for further development of the
business and to deal with the potential uncertainty and delay in executing its business plan in view
of COVID-19.
5. RESOLUTION 5 - RATIFICATION OF PRIOR ISSUE OF 34,860,021 SHARES – ORDINARY
RESOLUTION
5.1 Listing Rule 4.5 (the “15% Rule”) permits the Company to issue ordinary shares without approval
from the Company’s shareholders in certain limited circumstances.
On 28 April 2020 the Company undertook a Share Purchase Plan (SPP) seeking to raise $2 million
from the issue of 40 million new shares of 5 cents each. The SPP was oversubscribed by $1,128,000
and the Directors determined to accept the oversubscriptions. A further $615,000 was raised by way
of a placement to Wholesale investors.
On 21 May 2020, the Company issued 34,860,021 new ordinary fully paid shares at an issue price
of $0.05 per share to raise $1,743,000 in accordance with the 15% Rule (“SPP Oversubscription
Shares + Wholesale Placement”).
The SPP Oversubscription Shares were issued to shareholders of the Company. The Wholesale
Placement shares were issued to Wholesale Investors. The funds raised from the issues will be used
to further the development of the Truscreen device, for marketing and general working capital.
5.2 Listing Rule 4.5.1(c) allows the Company to renew its capacity to issue ordinary shares within
the 15% Rule, when it has been used, by obtaining subsequent ratification of the issue from
shareholders of the Company.

On 19 March 2020 the NZX under a class waiver increased the placement cap under Listing Rule
4.5.1 from 15% to 25% until 31 October 2020. The Company has availed itself of the additional
capacity for the Public Pool and Priority Offers in resolutions 6 and 7.
The Board is seeking the ratification by shareholders of the issue of 34,860,021 shares issued.

8


The effect of this Resolution will be to allow the Company to retain the flexibility to issue Equity
Securities in the future up to the 15% annual placement capacity set out in Listing Rule 4.1.2 without
the requirement to obtain prior Shareholder approval.
5.3 In the event the Resolution is not passed the Company will be restricted from issuing Equity
Securities other than in accordance with Listing Rule 4.1.2.
6. RESOLUTION 6 - RATIFICATION OF PRIOR ISSUE OF 10,000,000 SHARES – ORDINARY
RESOLUTION
6.1 Listing Rule 4.5 (the “15% Rule”) permits the Company to issue ordinary shares without approval
from the Company’s shareholders in certain limited circumstances.
On 29 May 2020, the Company issued 10,000,000 new ordinary fully paid shares at an issue price
of $0.05 per share to raise $500,000 in accordance with the 15% Rule (“Public Pool Shares”).
The Public Pool Shares were issued to a number of Wholesale and retail investors subsequent to
the Share Purchase Plan raising in May 2020. The funds raised from the issue will be used to further
the development of the Truscreen device, for marketing and general working capital.
6.2 Listing Rule 4.5.1(c) allows the Company to renew its capacity to issue ordinary shares within
the 15% Rule, when it has been used, by obtaining subsequent ratification of the issue from
shareholders of the Company.

On 19 March 2020 the NZX under a class waiver increased the placement cap under Listing Rule
4.5.1 from 15% to 25% until 31 October 2020. The Company has availed itself of this capacity to
issue the Public Pool shares.

The Board is seeking the ratification by shareholders of the previous issue of the Public Pool Shares.

The effect of this Resolution will be to allow the Company to retain the flexibility to issue Equity
Securities in the future up to the 15% annual placement capacity set out in Listing Rule 4.1.2 without
the requirement to obtain prior Shareholder approval.
6.3 In the event the Resolution is not passed the Company will be restricted from issuing Equity
Securities other than in accordance with Listing Rule 4.1.2.
7. RESOLUTION 7 - RATIFICATION OF PRIOR ISSUE OF 20,000,000 SHARES – ORDINARY
RESOLUTION
7.1 Listing Rule 4.5 (the “15% Rule”) permits the Company to issue ordinary shares without
approval from the Company’s shareholders in certain limited circumstances.
On 5 June 2020, the Company issued 20,000,000 new ordinary fully paid shares at an issue price of
$0.05 per share to raise $1,000,000 in accordance with the 15% Rule (“Priority Offer Shares”).
The Priority Offer Shares were issued to a NZX market participant subsequent to the Share
Purchase Plan raising in May 2020. The funds raised from the issue will be used to further the
development of the Truscreen device, for marketing and general working capital.
7.2 Listing Rule 4.5.1(c) allows the Company to renew its capacity to issue ordinary shares within
the 15% Rule, when it has been used, by obtaining subsequent ratification of the issue from
shareholders of the Company.

On 19 March 2020 the NZX under a class waiver increased the placement cap under Listing Rule
4.5.1 from 15% to 25% until 31 October 2020. The Company has availed itself of this capacity to
issue the Priority Offer Shares.

The Board is seeking the ratification by shareholders of the previous issue of the Priority Offer Shares.

9

The effect of this Resolution will be to allow the Company to retain the flexibility to issue Equity
Securities in the future up to the 15% annual placement capacity set out in Listing Rule 4.1.2 without
the requirement to obtain prior Shareholder approval.
7.3 In the event the Resolution is not passed the Company will be restricted from issuing Equity
Securities other than in accordance with Listing Rule 4.1.2.

10

SCHEDULE 1 DEFINITIONS
In this Notice and Explanatory Statement:
$ or NZ$ means New Zealand dollars.

Annual General Meeting or Meeting means the meeting convened by the Notice.

Board means the current board of directors of the Company.

Business Day means Monday to Friday inclusive, except New Year’s Day, Good Friday, Easter
Monday, Christmas Day, Boxing Day, and any other day that NZX declares is not a business
day.

Chair or Chairperson means the chair of the Meeting.

Company means Truscreen Limited

Constitution means the Company’s constitution.

Companies Act means the Companies Act 1993.

Directors means the current directors of the Company.

Explanatory Statement means the explanatory statement accompanying the Notice.

Equity Securities has the meaning giving in the NZX Listing Rules.

Notice or Notice of Meeting means this notice of meeting including the Explanatory Statement
and the Proxy Form.

NZX means ASX Limited or the financial market operated by NZX Limited, as the context
requires.

NZX Listing Rules means the Listing Rules of NZX.

Priority Offer means the offer outlined in an announcement to the NZX on 18 May 2020

Proxy Form means the proxy form accompanying the Notice.

Public Pool Offer means the offer outlined in an announcement to the NZX on 18 May 2020.

Resolutions means the resolutions set out in the Notice, or any one of them, as the context
requires.

Section means a section of the Explanatory Statement.

Share means a fully paid ordinary share in the capital of the Company.

Shareholder means a registered holder of a Share.

Share Purchase Plan means

Wholesale Investor means an investor as described in the Financial Markets Conduct Act 2013.

---

LODGE YOUR PROXY
Online:
https://investorcentre.linkmarketservices.co.nz/voting/TRU
Scan & email:
meetings@linkmarketservices.co.nz Mail:
Fax: +64 9 375 5990 Use the reply paid
Deliver: envelope or address to :
Link Market Services Link Market Services
Level 11, Deloitte Centre, PO Box 91976
80 Queen Street, Auckland 1010 Auckland 1142
Scan this QR code with your smartphone and vote online

General Enquiries
+64 9 375 5998 | enquiries@linkmarketservices.com

PROXY FORM/ADMISSION CARD FOR TRUSCREEN LIMITED’S 2020 ANNUAL MEETING
The Annual Meeting of TruScreen Limited (TruScreen) will be held online at www.virtualmeeting.co.nz/tru20 on Thursday 10 September 2020,
commencing at 12:00pm.
If you will attend the Meeting online, you will require your CSN/Holder Number for verification purposes.

If you will not attend the Meeting online but wish to be represented by proxy, please complete and return this form (in accordance with the lodgement
instructions above) to TruScreen’s share registry, Link Market Services, by no later than 12:00pm, Tuesday 8 September 2020.
You can also appoint your proxy and vote online by going to https://investorcentre.linkmarketservices.co.nz/voting/TRU or by scanning the QR code
above with your smartphone.

Appointment of proxy
A shareholder entitled to attend and vote is entitled to appoint a proxy or, in the case of a corporate shareholder, a representative to attend online and
vote instead of him/her and that proxy or representative need not also be a shareholder. The Chairperson of the meeting is willing to act as proxy for any
shareholder who wishes to appoint him for that purpose. If you appoint the Chairperson and you do not indicate how the Chairperson should vote, the
Chairperson will vote in favour of the resolutions.

Voting of your holding
Direct your proxy how to vote by making the appropriate election, either online or on this Proxy Form, in respect of each resolution. If you return this
form without directing the proxy how to vote on any particular matter, the proxy may vote as he/she thinks fit or abstain from voting. If you make more
than one election in respect of a resolution your vote will be invalid on that resolution. If you expressly appoint the Chairman of the Meeting as your
proxy and elect to give him discretion on how to vote on a resolution, you acknowledge that he will exercise your vote in favour of resolutions 1 to 7.

Voting Restrictions
Any person who has been issued, or has acquired, the Equity Securities which are subject to ratification by that resolution, and any Associated Person
of that person, may not act as a discretionary proxy in respect of Resolutions 5, 6 and 7, but may vote in accordance with express instructions.

Attending the meeting
The 2020 Annual Meeting will be held online only and shareholders can attend at www.virtualmeeting.co.nz/tru20. A corporation may appoint a person
to attend and vote online at the Meeting as its representative in the same manner as that in which it could appoint a proxy. That person need not also
be a shareholder.

Signing instructions for proxy forms
Individual
This Proxy Form must be signed by the shareholder or his/her/its attorney duly authorised in writing.
Joint Holding
In the case of a joint shareholding, this Proxy Form may be signed by either of the joint shareholders (or their duly authorised attorney).
Power of Attorney
This Proxy Form and the power of attorney or other authority, if any, under which it is signed, or a copy of that power or authority certified by a Solicitor,
Justice of the Peace or Notary Public must be deposited or mailed to be received at the office of Link Market Services Limited, in any manner as per the
instructions below, not later than 12:00pm on 8 September 2020.
Corporate Shareholder
In the case of a corporate shareholder, this Proxy Form must be signed by a director or a duly authorised officer acting under the express or implied
authority of the shareholder, or an attorney duly authorised by the shareholder.
Go online to https://investorcentre.linkmarketservices.co.nz/voting/TRU to appoint your proxy

PROXY/CORPORATE REPRESENTATIVE FORM
STEP 1: APPOINT A PROXY TO VOTE ON YOUR BEHALF
I/We being a shareholder(s) of TruScreen Limited hereby appoint:

________________________________________________________of ______________________________________________________
(full name of proxy) (e-mail address)

Or

________________________________________________________of ______________________________________________________
(full name of proxy) (e-mail address)
as my/our proxy to vote for me/us on my/our behalf at the Annual Meeting of the Company to be held on Thursday 10 September 2020 and at
any adjournment of that meeting and to vote on any resolutions to amend any of the resolutions, on any resolution so amended, and on any
other resolution proposed at the meeting (or any adjournment thereof). Unless otherwise instructed as above, the proxy will vote as he/she
thinks fit or abstain from voting on each such resolution. The proxy is appointed only in respect of the above meeting or any adjournment
thereof.
STEP 2: ITEMS OF BUSINESS – PROXY VOTING INSTRUCTIONS
Complete this part if you have appointed a proxy above and you want to direct the proxy as to how the proxy should vote.
Please note: For each resolution you must tick one box. If you mark the abstain box for an item, you are directing your proxy not to vote on
your behalf during polling and your votes will not be counted computing the required majority, for that item
ORDINARY BUSINESS
To consider and, if thought fit, pass the following ordinary resolutions:

Tick (✓) in box to vote

For Against Abstain Discretion
1.
That the Shareholders ratify the appointment of RSM Hayes Audit Auckland on
17 February 2020.
   
2.
That the Board be authorised to fix the remuneration of RSM Hayes Audit
Auckland the Company’s auditors.
   
3.
That Ms Juliet Hull, who was nominated as a non-executive director of the
Company, and having consented to act, be elected as a Director of the Company.
   
4.
That Mr Anthony Ho, who retires in accordance with the provisions of the
Constitution of the Company, and being eligible, offers himself for re-election, be
re-elected as a Director of the Company.
   
5.
That shareholders ratify the previous issue by the Company on 21 May 2020 of
34,860,021 ordinary fully paid shares at an issue price of 5 cents per share.
   
6.
That shareholders ratify the previous issue by the Company on 29 May 2020 of
10,000,000 ordinary fully paid shares at an issue price of 5 cents per share.
   
7.
That shareholders ratify the previous issue by the Company on 5 June 2020 of
20,000,000 ordinary fully paid shares at an issue price of 5 cents per share.
   

STEP 3: SIGN: SIGNATURE OF SHAREHOLDER(S) This section must be completed
Shareholder 1 Shareholder 2 Shareholder 3

or duly authorised officer or attorney or duly authorised officer or attorney or duly authorised officer or attorney
Contact Name ___________________________________________ Contact Daytime Telephone _______________________ Date ____________
Electronic Investor Communications: If you received the Notice of Meeting and Proxy Form by mail and wish to receive your future investor
communications by email please provide your email address below.

---

13 August 2020
Dear Shareholder,
Shareholders are invited to the 2020 Annual Meeting (AM) which is scheduled for 10
September 2020.
At the forthcoming AM we will be bidding farewell to one of our directors, Mr. Con Hickey
who indicated to the board in early 2020 that due to his growing business commitments
that he would be retiring from the board at the conclusion of the AM.
On behalf of the board, I thank him for his contributions and time devoted to the affairs of
the Company. Auckland based; Ms Juliet Hull has been nominated for election as the
incoming director. Her background and experience are outlined in the Explanatory Notes
of the Notice of Meeting.
The details of the Annual Meeting are as follows:
Given COVID-19 restrictions the meeting will be a virtual meeting with details as follows:
Online at www.virtualmeeting.co.nz/tru20
Virtual Annual Meeting Shareholders will only be able to attend and participate in the
Annual General Meeting virtually via an online platform provided by our share registrar,
Link Market Services at www.virtualmeeting.co.nz/tru20.
Shareholders attending and participating in the Annual Meeting virtually via the online
platform will be able to vote and ask questions during the meeting. More information
regarding virtual attendance at the Annual Meeting (including how to vote and ask
questions virtually during the Meeting) is available in the Virtual General Meeting Online
Portal Guide available at
https://bcast.linkinvestorservices.co.nz/generic/docs/OnlinePortalGuide.pdf
Date: 10 September 2020
Time; 12.00pm Auckland, New Zealand time.
Accompanying this letter is a Notice of the Annual Meeting and a Proxy Form which must
be lodged at least 48 hours before the meeting.
Please note that this meeting is restricted to registered shareholders and/or proxy holders.
Yours sincerely,

Anthony Ho
Chairman

For more information visit www.TruScreen.com or contact:

TruScreen
Guy Robertson
CFO
guyrobertson@truscreen.com





About TruScreen:
Watch our video on TruScreen: http://truscreen.com/truscreen-the-company/truscreen-
ultra-video/
TruScreen is a Cervical Cancer Screening Device
which offers the latest technology in cervical
screening, providing real-time, accurate detection
of pre-cancerous and cancerous cervical cells to
help improve the health and well-being of women
around the world. TruScreen’s real-time cervical cancer
technology utilises a digital wand which is placed on the surface
of the cervix to measure electrical and optical signals from the
surrounding tissues. A sophisticated proprietary algorithm
framework is utilised to detect pre-cancerous change, or cervical
intraepithelial neoplasia (CIN), by optical and electrical measurement of cervical tissue.
TruScreen offers an alternative approach to cervical screening, resolving many of the
ongoing issues with Pap tests including failed samples, poor patient follow up, patient
discomfort and the need for supporting laboratory infrastructures. As such, TruScreen
target market is developing countries where no large scale cervical cancer screening
programs and infrastructure are in place, such as; China, Mexico, Africa, Russia and India.
TruScreen’s cervical cancer screening device is EC certified for use throughout Europe and
CFDA approved for sale in China. Truscreen gained recognition from Global NGO’s WHO and
Unitaid in a joint Cervical Cancer Technology Landscape released at the 72
nd
World Health
Assembly.
For more information, visit our website at www.truscreen.com